• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLTA MEDICAL THERMAGE CPT SYSTEM; ELECTROSURGICAL,CUTTING & COAGULATION & ACC.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLTA MEDICAL THERMAGE CPT SYSTEM; ELECTROSURGICAL,CUTTING & COAGULATION & ACC. Back to Search Results
Model Number TTNS3.00E2-900
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Erythema (1840); Swelling (2091); Partial thickness (Second Degree) Burn (2694)
Event Date 05/05/2020
Event Type  Injury  
Manufacturer Narrative
The treatment tip is not available for return, as it has been discarded.Lot information has been requested but not yet received.Based on all the available information no casual factors can be determined and no conclusions can be drawn.
 
Event Description
A physician reported that a consumer experienced blisters on their face after undergoing a thermage treatment.After the procedure the physician applied scald ointment and ice to the red and swollen areas.The blisters were noticed the next day and no additional treatment was prescribed.It is unknown at this time if there will be permanent damage of scarring.Prior to starting treatment, the patient requested that an energy level of 12 be used during the procedure.The physician advised the patient that the highest level of energy that could be used was an 8 and advised that blisters may occur if the requested level is used.During the procedure the physician lowered the energy level to 6.5.No errors occurred during treatment and it was the first time the tip was used.The tip was inspected prior to treatment and after every 100 pulses during.The treatment tip is no longer available for return.
 
Manufacturer Narrative
Burns, blisters, scabbing, and scarring are all known possible adverse patient reactions to thermage treatment.Thermage system technical user¿s manual (p009240-05 rev.B) states the procedure may produce heating in the upper layers of the skin, causing burns and subsequent blister and scab formation.There is a small chance of scar formation.Application of topical steroidal or antibiotic preparations may be of benefit.It is the physician responsibility to ensure the treatment is being performed in a safe manner and adequate education is provided to the patient about possible adverse events.The treatment tip was discarded and the treating clinic refuses to provide the log data.Based on the available information, no causal factors can be determined and no conclusion can be found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMAGE CPT SYSTEM
Type of Device
ELECTROSURGICAL,CUTTING & COAGULATION & ACC.
Manufacturer (Section D)
SOLTA MEDICAL
11720 n creek parkway n
ste 100
bothell WA 98011
MDR Report Key10361687
MDR Text Key201897535
Report Number3011423170-2020-00062
Device Sequence Number1
Product Code GEI
Combination Product (y/n)Y
PMA/PMN Number
K132431
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/01/2005,05/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTTNS3.00E2-900
Device Catalogue NumberTTNS3.00E2-900
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 05/07/2020
Initial Date FDA Received08/04/2020
Supplement Dates Manufacturer Received05/07/2020
Supplement Dates FDA Received01/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age38 YR
-
-